Latest Lemaitre Vascular (LMAT) Headlines Nevad
Post# of 35
Posted On: 03/13/2014 10:38:10 AM
Latest Lemaitre Vascular (LMAT) Headlines
Nevada Copper VP Appointed as SME President-Designate
Marketwire - Wed Feb 26, 6:32AM CST
Nevada Copper Corp. (TSX: NCU) ("Nevada Copper" or "Company") is pleased to announce that Mr. Timothy Arnold, Vice President Operations for Nevada Copper, has been named by the Society for Mining, Metallurgy and Exploration's ("SME") Nominating Committee as its candidate for President-elect Designate. Subject to ratification in February of 2015, Mr. Arnold would serve as President of the Society from February 2016 to February 2017.
LeMaitre Q4 2013 Record Sales of $17.9mm (+21%)
GlobeNewswire - Tue Feb 25, 3:05PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2013 and full-year 2013 financial results. The Company increased its dividend to $0.035/share and provided Q1 2014 and full-year 2014 guidance.
LeMaitre Vascular to Present at Three Upcoming Investor Conferences
GlobeNewswire - Mon Feb 24, 12:58PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences. The first is the Cowen and Company Healthcare Conference at the Boston Marriott Copley Place in Boston, MA, on Monday, March 3, 2014. The second is the ROTH Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, CA, on Monday, March 10, 2014. The third is the BTIG Medical Technology, Diagnostics, and Healthcare IT Conference at The Cliff Lodge in Snowbird, UT, on Tuesday, March 18, 2014. Management will provide an update on the Company at all three conferences.
LeMaitre Vascular Will Announce Fourth Quarter 2013 Earnings Results on February 25, 2014
GlobeNewswire - Thu Feb 20, 11:07AM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its fourth quarter 2013 financial results on February 25, 2014, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Emerald Oil Inc acquires USD75.1m Williston Basin leasehold
M2 - Fri Feb 14, 6:58AM CST
Oil exploration and production operator Emerald Oil Inc (NYSE MKT:EOX) stated on Thursday that it has acquired the core Bakken and Three Forks producing properties and undeveloped leasehold in McKenzie and Williams Counties, North Dakota for a total purchase price of USD75.1m in cash.
ProductionHUB Modernizes the Hiring Process for Jobseekers in Video Trade Unions
Marketwire - Tue Jan 14, 9:02AM CST
ProductionHUB, the pro video marketplace, makes it easier to hire video production professionals in relevant trade unions.
Stryker Buys Patient Safety - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 3:40PM CST
SYK decided to buy Irvine, Calif.-based Patient Safety Technologies in order to utilize Patient Safety's device to lessen the risk of surgical sponges being left in patients after surgery
LeMaitre to Sell Direct-to-Hospital in Australia and Norway
GlobeNewswire - Thu Jan 02, 3:18PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has begun selling Direct-to-Hospital in Australia and Norway in January 2014.
U.S. Market for Peripheral Vascular Devices and Accessories Research Report
M2 - Mon Dec 09, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/92nl6f/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories" report to their offering. By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. Key Topics Covered: List of Figures List of Charts Executive Summary Research Methodology U.S. Peripheral Vascular Device Market Overview Peripheral Vascular Stent Market Pta Balloon Catheter Market Atherectomy Device Market Chronic Total Occlusion Device Market Embolic Protection Device Market Stent Graft Market Surgical Graft Market Arteriovenous (Av) Access Thrombectomy Device Market Inferior Vena Cava Filter Market Diagnostic And Interventional Catheter Market Diagnostic And Interventional Guidewire Market Introducer Sheath Market Vascular Closure Device Market Transcatheter Embolization Device Market Abbreviations Companies Mentioned - ALN International Inc. - B. Braun - C. R. Bard - Endologix - IDEV Technologies - LeMaitre Vascular - Maquet - Spectranetics - Teleflex Medical - W. L. Gore and many more... For more information visit http://www.researchandmarkets.com/research/92...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
LeMaitre Vascular to Present at the Benchmark Company Micro Cap Discovery Conference on Wednesday, December 11, 2013
GlobeNewswire - Wed Nov 27, 12:44PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Benchmark Company Micro Cap Discovery Conference at the Palmer House Hilton, Chicago, IL, on Wednesday, December 11, 2013. JJ Pellegrino, Chief Financial Officer, will provide an update on the company in one-on-one meetings with investors.
LeMaitre Vascular Announces Appointment of Michael Thomas to Its Board of Directors
GlobeNewswire - Mon Nov 11, 7:46AM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today changes in the composition of its Board of Directors.
LeMaitre Vascular to Participate in Two Investor Conferences in November 2013
GlobeNewswire - Fri Nov 08, 4:19PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two upcoming Investor Conferences. The first is the Three Part Advisors Southwest IDEAS Investor Conference at the Sheraton Dallas Hotel in Dallas, TX, on Wednesday, November 20, 2013. The second is the Brean Capital 2013 Life Sciences Summit at Convene in New York, NY, on Monday, November 25, 2013. Management will provide an update on the Company at both conferences.
LeMaitre Vascular Announces Details for Its November 12th & 13th Investor and Analyst Days
GlobeNewswire - Wed Nov 06, 5:39PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will webcast its investor and analyst days to be held on November 12 and 13. These events will be hosted and webcast live from two locations:
LeMaitre Q3 2013 Sales $15.3mm (+12%)
GlobeNewswire - Tue Oct 29, 3:06PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2013 financial results. The Company posted sales of $15.3mm and operating income of $0.8mm. The Company also announced a $0.03/share dividend and provided Q4 2013 and full-year 2013 guidance.
LeMaitre Vascular to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14, 2013
GlobeNewswire - Fri Oct 25, 4:52PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at 3:00 pm EST.
Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016: Leading Players Investing Heavily in R&D
M2 - Fri Sep 20, 6:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v25k5/global) has announced the addition of the "Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016" report to their offering. The analysts forecast the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at a CAGR of 10.67 percent over the period 201-2016. One of the key factors contributing to this market growth is the high prevalence of abdominal aortic aneurysms. The Global Endovascular Abdominal Aortic Aneurysm Repair Devices market has also been witnessing the increasing demand for minimally invasive surgeries. However, the risk of complications and re-interventions associated with endovascular abdominal aortic aneurysm repair procedures could pose a challenge to the growth of this market. Commenting on the report, an analyst from the team said: One of the main trends witnessed in the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market is the increasing number of mergers and acquisitions. Several leading vendors in the Global Endovascular AAA Repair Devices market have been focusing on mergers and acquisitions strategy to increase its global presence, mitigate of patent expiration losses, and achieve high economies of scale. For instance, Medtronic Inc. recently completed its acquisition of two privately held companies, PEAK Surgical Inc. and Salient Surgical Technologies Inc., to expand its innovative surgical product portfolio to meet the global customer and patient needs. According to the report, one of the main factors driving the market is prevalence of favorable reimbursement policies. To minimize the overall cost for patients, some countries have provided insurance schemes through which patients can be reimbursed for the cost of the treatment incurred. Further, the report states that one of the main challenges is the intense vendor competition. The global leading players are investing heavily in R&D to produce a broad range of advanced and high-end stents. Small and medium-sized vendors, however, are focused on marketing a single product line to a specific region in the globe, which is increasing the competition within the market. Companies Mentioned - Aptus Endosystems Inc. - Cardiatis S.A. - Cook Medical Inc. - Cordis Corp. - Endologix Inc. - JOTEC GmbH - LeMaitre Vascular Inc. - Lombard Medical Technologies PLC - Medtronic Inc. - Nano Endoluminal - Terumo Cardiovascular Systems Corp. - TriVascular Inc.. - W. L. Gore & Associates For more information visit http://www.researchandmarkets.com/research/8v25k5/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX Ends EVOLVE II Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 17, 1:20PM CDT
Boston Scientific finishes patient enrollment for the EVOLVE II trial.
LeMaitre Vascular to Host Two Investor and Analyst Days: November 12 & 13, 2013
GlobeNewswire - Wed Sep 11, 4:10PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will host November 2013 investor and analyst days in two locations:
SeaChange International interim CFO is permanent
AP - Thu Sep 05, 2:12PM CDT
ACTON, Mass. (AP) — Video software company SeaChange International said Thursday that its interim chief financial officer was appointed to the job on a permanent basis.
ResMed Completes Patient Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 04, 1:10PM CDT
ResMed rounds off patient enrollment for international SERVE-HF study.
Nevada Copper VP Appointed as SME President-Designate
Marketwire - Wed Feb 26, 6:32AM CST
Nevada Copper Corp. (TSX: NCU) ("Nevada Copper" or "Company") is pleased to announce that Mr. Timothy Arnold, Vice President Operations for Nevada Copper, has been named by the Society for Mining, Metallurgy and Exploration's ("SME") Nominating Committee as its candidate for President-elect Designate. Subject to ratification in February of 2015, Mr. Arnold would serve as President of the Society from February 2016 to February 2017.
LeMaitre Q4 2013 Record Sales of $17.9mm (+21%)
GlobeNewswire - Tue Feb 25, 3:05PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2013 and full-year 2013 financial results. The Company increased its dividend to $0.035/share and provided Q1 2014 and full-year 2014 guidance.
LeMaitre Vascular to Present at Three Upcoming Investor Conferences
GlobeNewswire - Mon Feb 24, 12:58PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences. The first is the Cowen and Company Healthcare Conference at the Boston Marriott Copley Place in Boston, MA, on Monday, March 3, 2014. The second is the ROTH Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, CA, on Monday, March 10, 2014. The third is the BTIG Medical Technology, Diagnostics, and Healthcare IT Conference at The Cliff Lodge in Snowbird, UT, on Tuesday, March 18, 2014. Management will provide an update on the Company at all three conferences.
LeMaitre Vascular Will Announce Fourth Quarter 2013 Earnings Results on February 25, 2014
GlobeNewswire - Thu Feb 20, 11:07AM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its fourth quarter 2013 financial results on February 25, 2014, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Emerald Oil Inc acquires USD75.1m Williston Basin leasehold
M2 - Fri Feb 14, 6:58AM CST
Oil exploration and production operator Emerald Oil Inc (NYSE MKT:EOX) stated on Thursday that it has acquired the core Bakken and Three Forks producing properties and undeveloped leasehold in McKenzie and Williams Counties, North Dakota for a total purchase price of USD75.1m in cash.
ProductionHUB Modernizes the Hiring Process for Jobseekers in Video Trade Unions
Marketwire - Tue Jan 14, 9:02AM CST
ProductionHUB, the pro video marketplace, makes it easier to hire video production professionals in relevant trade unions.
Stryker Buys Patient Safety - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 3:40PM CST
SYK decided to buy Irvine, Calif.-based Patient Safety Technologies in order to utilize Patient Safety's device to lessen the risk of surgical sponges being left in patients after surgery
LeMaitre to Sell Direct-to-Hospital in Australia and Norway
GlobeNewswire - Thu Jan 02, 3:18PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has begun selling Direct-to-Hospital in Australia and Norway in January 2014.
U.S. Market for Peripheral Vascular Devices and Accessories Research Report
M2 - Mon Dec 09, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/92nl6f/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories" report to their offering. By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. Key Topics Covered: List of Figures List of Charts Executive Summary Research Methodology U.S. Peripheral Vascular Device Market Overview Peripheral Vascular Stent Market Pta Balloon Catheter Market Atherectomy Device Market Chronic Total Occlusion Device Market Embolic Protection Device Market Stent Graft Market Surgical Graft Market Arteriovenous (Av) Access Thrombectomy Device Market Inferior Vena Cava Filter Market Diagnostic And Interventional Catheter Market Diagnostic And Interventional Guidewire Market Introducer Sheath Market Vascular Closure Device Market Transcatheter Embolization Device Market Abbreviations Companies Mentioned - ALN International Inc. - B. Braun - C. R. Bard - Endologix - IDEV Technologies - LeMaitre Vascular - Maquet - Spectranetics - Teleflex Medical - W. L. Gore and many more... For more information visit http://www.researchandmarkets.com/research/92...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
LeMaitre Vascular to Present at the Benchmark Company Micro Cap Discovery Conference on Wednesday, December 11, 2013
GlobeNewswire - Wed Nov 27, 12:44PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Benchmark Company Micro Cap Discovery Conference at the Palmer House Hilton, Chicago, IL, on Wednesday, December 11, 2013. JJ Pellegrino, Chief Financial Officer, will provide an update on the company in one-on-one meetings with investors.
LeMaitre Vascular Announces Appointment of Michael Thomas to Its Board of Directors
GlobeNewswire - Mon Nov 11, 7:46AM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today changes in the composition of its Board of Directors.
LeMaitre Vascular to Participate in Two Investor Conferences in November 2013
GlobeNewswire - Fri Nov 08, 4:19PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two upcoming Investor Conferences. The first is the Three Part Advisors Southwest IDEAS Investor Conference at the Sheraton Dallas Hotel in Dallas, TX, on Wednesday, November 20, 2013. The second is the Brean Capital 2013 Life Sciences Summit at Convene in New York, NY, on Monday, November 25, 2013. Management will provide an update on the Company at both conferences.
LeMaitre Vascular Announces Details for Its November 12th & 13th Investor and Analyst Days
GlobeNewswire - Wed Nov 06, 5:39PM CST
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will webcast its investor and analyst days to be held on November 12 and 13. These events will be hosted and webcast live from two locations:
LeMaitre Q3 2013 Sales $15.3mm (+12%)
GlobeNewswire - Tue Oct 29, 3:06PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2013 financial results. The Company posted sales of $15.3mm and operating income of $0.8mm. The Company also announced a $0.03/share dividend and provided Q4 2013 and full-year 2013 guidance.
LeMaitre Vascular to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14, 2013
GlobeNewswire - Fri Oct 25, 4:52PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at 3:00 pm EST.
Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016: Leading Players Investing Heavily in R&D
M2 - Fri Sep 20, 6:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v25k5/global) has announced the addition of the "Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016" report to their offering. The analysts forecast the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at a CAGR of 10.67 percent over the period 201-2016. One of the key factors contributing to this market growth is the high prevalence of abdominal aortic aneurysms. The Global Endovascular Abdominal Aortic Aneurysm Repair Devices market has also been witnessing the increasing demand for minimally invasive surgeries. However, the risk of complications and re-interventions associated with endovascular abdominal aortic aneurysm repair procedures could pose a challenge to the growth of this market. Commenting on the report, an analyst from the team said: One of the main trends witnessed in the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market is the increasing number of mergers and acquisitions. Several leading vendors in the Global Endovascular AAA Repair Devices market have been focusing on mergers and acquisitions strategy to increase its global presence, mitigate of patent expiration losses, and achieve high economies of scale. For instance, Medtronic Inc. recently completed its acquisition of two privately held companies, PEAK Surgical Inc. and Salient Surgical Technologies Inc., to expand its innovative surgical product portfolio to meet the global customer and patient needs. According to the report, one of the main factors driving the market is prevalence of favorable reimbursement policies. To minimize the overall cost for patients, some countries have provided insurance schemes through which patients can be reimbursed for the cost of the treatment incurred. Further, the report states that one of the main challenges is the intense vendor competition. The global leading players are investing heavily in R&D to produce a broad range of advanced and high-end stents. Small and medium-sized vendors, however, are focused on marketing a single product line to a specific region in the globe, which is increasing the competition within the market. Companies Mentioned - Aptus Endosystems Inc. - Cardiatis S.A. - Cook Medical Inc. - Cordis Corp. - Endologix Inc. - JOTEC GmbH - LeMaitre Vascular Inc. - Lombard Medical Technologies PLC - Medtronic Inc. - Nano Endoluminal - Terumo Cardiovascular Systems Corp. - TriVascular Inc.. - W. L. Gore & Associates For more information visit http://www.researchandmarkets.com/research/8v25k5/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX Ends EVOLVE II Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 17, 1:20PM CDT
Boston Scientific finishes patient enrollment for the EVOLVE II trial.
LeMaitre Vascular to Host Two Investor and Analyst Days: November 12 & 13, 2013
GlobeNewswire - Wed Sep 11, 4:10PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will host November 2013 investor and analyst days in two locations:
SeaChange International interim CFO is permanent
AP - Thu Sep 05, 2:12PM CDT
ACTON, Mass. (AP) — Video software company SeaChange International said Thursday that its interim chief financial officer was appointed to the job on a permanent basis.
ResMed Completes Patient Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 04, 1:10PM CDT
ResMed rounds off patient enrollment for international SERVE-HF study.
(0)
(0)LeMaitre Vascular (LMAT) Stock Research Links
Scroll down for more posts ▼